Stem Cells http://www.epitomics.com
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online March 6, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2007-0857v1
2007-0857v2
26/6/1436    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Google Scholar
Right arrow Articles by Hohenstein, K. A.
Right arrow Articles by Donovan, P. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hohenstein, K. A.
Right arrow Articles by Donovan, P. J.
Submitted on October 10, 2007
Accepted on February 23, 2008

EMBRYONIC STEM CELLS

Nucleofection Mediates High-efficiency Stable Gene Knockdown and Transgene Expression in Human Embryonic Stem Cells

Kristi A. Hohenstein 1, April D. Pyle 2, Jing Yi Chern 3, Leslie F. Lock 4, Peter J. Donovan 4*

1 Human Genetics and Molecular Biology Training Program, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine. Baltimore, MD 21205.; Sue and Bill Gross Stem Cell Research Program, Department of Biological Chemistry, Developmental and Cell Biology Department, Center for Molecular and Mitochondrial Medicine and Genetics, University of California. Irvine, CA 92697
2 Department of Microbiology, Immunology and Molecular Genetics. University of California. Los Angeles, CA 90095
3 Institute of Cell Engineering, Stem Cell Program, Johns Hopkins University School of Medicine. Baltimore, MD. 21205
4 Sue and Bill Gross Stem Cell Research Program, Department of Biological Chemistry, Developmental and Cell Biology Department, Center for Molecular and Mitochondrial Medicine and Genetics, University of California. Irvine, CA 92697

* To whom correspondence should be addressed. E-mail: pdonovan{at}uci.edu.

Correspondence my also be addressed to Leslie F. Lock at llock@uci.edu


   Abstract

High-efficiency genetic modification of human embryonic stem (hES) cells would enable manipulation of gene activity, routine gene targeting, and development of new human disease models and treatments. Chemical transfection, nucleofection, and electroporation of hES cells result in low transfection efficiencies. Viral transduction is efficient, but has significant drawbacks. Here we describe techniques to transiently and stably express transgenes in hES cells with high efficiency using a widely available vector system. The technique combines nucleofection of single hES cells with improved methods to select hES cells at clonal density. As validation, we reduced Oct4 and Nanog expression using siRNAs and shRNA vectors in hES cells. Further, we derived many hES cell clones with either stably reduced alkaline phosphatase activity or stably overexpressed hrGFP. These clones retained stem cell characteristics; normal karyotype, stem cell marker expression, self-renewal, and pluripotency. These studies will accelerate efforts to interrogate gene function and define the parameters that control growth and differentiation of hES cells.

Key Words. human embryonic stem cells, nucleofection, transfection, transgene expression, RNA interference, GFP, Oct4, Nanog







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.epitomics.com
Copyright © 2008 by AlphaMed Press.